Thomas Jefferson University Hospital Department of Otolaryngology- Head and Neck Surgery, 925 Chestnut Street, 6th Floor, Philadelphia, PA, ,19107, USA.
J Otolaryngol Head Neck Surg. 2019 Nov 19;48(1):64. doi: 10.1186/s40463-019-0387-y.
Parotidectomy is a common treatment option for parotid neoplasms and the complications associated with this procedure can cause significant morbidity. Reconstruction following parotidectomy is utilized to address contour deformity and facial nerve paralysis. This study aims to demonstrate national trends in parotidectomy patients and identify factors associated with adverse postoperative outcomes. This study includes the largest patient database to date in determining epidemiologic trends, reconstructive trends, and prevalence of adverse events following parotidectomy.
A retrospective review was performed for parotidectomies included in the ACS-NSQIP database between January 2012 and December 2017. CPT codes were used to identify the primary and secondary procedures performed. Univariate and multivariate analysis was utilized to determine associations between pre- and perioperative variables with patient outcomes. Preoperative demographics, surgical indications, and common medical comorbidities were collected. CPT codes were used to identify patients who underwent parotidectomy with or without reconstruction. These pre- and perioperative characteristics were compared with 30-day surgical complications, medical complications, reoperation, and readmission using uni- and multivariate analyses to determine predictors of adverse events.
There were 11,057 patients who underwent parotidectomy. Postoperative complications within 30 days were uncommon (1.7% medical, 3.8% surgical), with the majority of these being surgical site infection (2.7%). Free flap reconstruction, COPD, bleeding disorders, smoking, and presence of malignant tumor were the strongest independent predictors of surgical site infection. Readmission and reoperation were uncommon at an incidence of 2.1% each. The strongest factors predictive of readmission were malignant tumor and corticosteroid usage. The strongest factors predictive of reoperation were free flap reconstruction, malignant tumor, bleeding disorder, and disseminated cancer. Surgical volume/contour reconstruction was relatively uncommon (18%). Facial nerve sacrifice was uncommon (3.7%) and, of these cases, only 25.5% underwent facial nerve reinnervation and 24.0% underwent facial reanimation.
There are overall low rates of complications, readmissions, and reoperations following parotidectomy. However, certain factors are predictive of adverse postoperative events and this data may serve to guide management and counseling of patients undergoing parotidectomy. Concurrent reconstructive procedures are not commonly reported which may be due to underutilization or underreporting.
腮腺切除术是治疗腮腺肿瘤的常见方法,该手术相关并发症可导致显著的发病率。腮腺切除术后进行重建是为了解决轮廓畸形和面神经瘫痪问题。本研究旨在展示腮腺切除术患者的全国趋势,并确定与不良术后结果相关的因素。本研究包括迄今为止最大的患者数据库,用于确定流行病学趋势、重建趋势以及腮腺切除术后不良事件的发生率。
对 2012 年 1 月至 2017 年 12 月期间 ACS-NSQIP 数据库中包含的腮腺切除术进行回顾性分析。使用 CPT 代码识别主要和次要手术程序。使用单变量和多变量分析确定术前和围手术期变量与患者结局之间的关联。收集术前人口统计学、手术指征和常见的合并症。使用 CPT 代码识别接受腮腺切除术加或不加重建的患者。使用单变量和多变量分析比较这些术前和围手术期特征与 30 天手术并发症、医疗并发症、再次手术和再入院情况,以确定不良事件的预测因素。
共有 11057 例患者接受了腮腺切除术。术后 30 天内的并发症并不常见(医疗并发症 1.7%,手术并发症 3.8%),其中大多数为手术部位感染(2.7%)。游离皮瓣重建、COPD、出血性疾病、吸烟和恶性肿瘤是手术部位感染的最强独立预测因素。再入院和再次手术的发生率均为 2.1%。预测再入院的最强因素是恶性肿瘤和皮质类固醇的使用。预测再次手术的最强因素是游离皮瓣重建、恶性肿瘤、出血性疾病和转移性癌症。手术量/轮廓重建相对较少(18%)。面神经牺牲并不常见(3.7%),其中只有 25.5%的患者接受了面神经再神经支配,24.0%的患者接受了面部再运动。
腮腺切除术后总体并发症、再入院和再次手术的发生率较低。然而,某些因素是不良术后事件的预测因素,这些数据可能有助于指导接受腮腺切除术的患者的管理和咨询。同时进行的重建手术并不常见,这可能是由于利用率低或报告不足。